2018 Annual Meeting | C87 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II

Date Monday 04/23/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jeffrey M. Gelfand, MD, MAS, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the differential diagnosis of neurological manifestations of systemic inflammatory, autoimmune, and rheumatological diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neuro-rheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
03:30 PM - 04:10 PM	Speaker	CNS Vasculitis and Mimics Rula Hajj-Ali, MD
04:10 PM - 04:50 PM	Speaker	Neurosarcoidosis, Pachymeningitis, Behcet's Disease Jeffrey M. Gelfand, MD, MAS, FAAN
04:50 PM - 05:30 PM	Speaker	Case Discussions with Faculty Neurologists and Rheumatologists; Questions and Answers

Faculty Disclosures
Jeffrey M. Gelfand, MD, MAS, FAAN	Dr. Gelfand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Rula Hajj-Ali, MD	Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Rula Hajj-Ali, MD has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��